Results 11 to 20 of about 79,367 (221)
ISTH guidelines for treatment of thrombotic thrombocytopenic purpura
Journal of Thrombosis and Haemostasis, 2020 Despite advances in treatment options for thrombotic thrombocytopenic purpura (TTP), there are still limited high quality data to inform clinicians regarding its appropriate treatment.
X. L. Zheng +13 more
semanticscholar +1 more source
ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura
Journal of Thrombosis and Haemostasis, 2020 Despite an increase in our understandings of pathogenesis of thrombotic thrombocytopenic purpura (TTP), the approaches for initial diagnosis and management of TTP vary significantly.
X. L. Zheng +13 more
semanticscholar +1 more source
Autoimmune thrombocytopenic purpura [PDF]
The American Journal of the Medical Sciences, 1971 Abstract Adult autoimmune throbocytopenic purpura (ATP) is a platelet disorder that develops in certain individuals with a genetic as well as sex (female) predisposition following an environment event (?viral). This results in the production of an IgG antiplatelet antibody capable of reacting with the host's platelets, as well as ...
openaire +7 more sources
A case of immune thrombocytopenic purpura presenting with intracranial hemorrhage
Journal of Acute Disease, 2013 Immune thrombocytopenic purpura is an acute, generally considered a self-limiting benign disorder with a 60%-80% change of spontaneous recovery occurring usually within a few months after onset.
Sinan Akbayram +5 more
doaj +1 more source
Journal of Thrombosis and Haemostasis, 2020 Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare, life‐threatening autoimmune thrombotic microangiopathy. Current standard of care is therapeutic plasma exchange, immunosuppression, and caplacizumab, an anti‐von Willebrand factor nanobody ...
L. Völker +7 more
semanticscholar +1 more source
Journal of Thrombosis and Haemostasis, 2020 Despite advances in treatment options for thrombotic thrombocytopenic purpura (TTP), there are still limited high quality data to inform clinicians regarding its management.
X. L. Zheng +13 more
semanticscholar +1 more source
Idiopathic thrombocytopenic purpura
Contemporary Clinical Dentistry, 2014 Idiopathic thrombocytopenic purpura (ITP) is defined as a hematologic disorder, characterized by isolated thrombocytopenia without a clinically apparent cause. The major causes of accelerated platelet consumption include immune thrombocytopenia, decreased bone marrow production, and increased splenic sequestration.
Khushboo Singh +2 more
openaire +3 more sources
Thrombotic Thrombocytopenic Purpura in Dengue Fever
Acta Medica Indonesiana, 2021 Thrombotic thrombocytopenic purpura is a rare but life threatening medical condition. Early recognition and treatment of thrombotic thrombocytopenic purpura is important especially in patients who do not present with the classic pentad to reduce the ...
Tze Yuan Tee, Rizna Abdul Cader
doaj
Thrombocytopenic purpura as only manifestation of brucellosis in a child
The Turkish Journal of Pediatrics, 2004 Thrombocytopenic purpura associated with brucellosis has been rarely reported in the world literature. Thrombocytopenic purpura is generally part of the array of manifestations of brucellosis such as fever, arthritis, malaise and ...
Mehmet Yalaz +2 more
doaj +1 more source
Thrombotic thrombocytopenic purpura [PDF]
memo - Magazine of European Medical Oncology, 2018 Thrombotic thrombocytopenic purpura (TTP) is a clearly defined entity of the thrombotic microangiopathies (TMA), a heterogeneous group of disorders characterized by microangiopathic hemolytic anemia with red cell fragmentation, thrombocytopenia and organ dysfunction due to disturbed microcirculation.
openaire +3 more sources